SPY769.95+0.04%QQQ722.18+0.13%BTC/USD80,811.000.00%DIA523.52+0.05%GLD372.26−0.01%TLT81.52−0.13%
BenzingaPremium Services
Premium Services
James Gornick

James Gornick

Benzinga Contributor

Articles by James Gornick

A Penny Stock To Watch In Challenging Cancer Space
A Penny Stock To Watch In Challenging Cancer Space
The author has a $2.75 Price Target on CytoDyn (CYDY) in the Next 6 to 12 months, representing significant upside from its current price of around $0.32.
New FDA Leadership Could Raise The Bar For Drug Approvals
New FDA Leadership Could Raise The Bar For Drug Approvals
A former critic of FDA and Pharma will now oversee the regulation of costly and complicated biologics like vaccines, gene therapies, and blood supply.
Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved